Terms ending in 2037
Every in-force patent on Acceleron Pharma Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,307,455 | Activin Type 2 Receptor Antibodies In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | |
| US 11,000,565 | Methods of Increasing Muscle Mass by Administration of Activin Type 2 Receptor Antibodies In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | |
| US 12,042,524 | Activin Type 2 Receptor Binding Proteins and Methods of Making Them In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | |
| US 12,258,380 | ALK4:ACTRIIB Heteromultimers and Uses Thereof In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | |
| US 11,059,894 | ALK7 Binding Proteins and Uses Thereof In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | |
| US 11,981,738 | ALK7 Binding Proteins and Methods of Reducing ALK7 Activity Using the Same In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | |
| US 11,471,510 | Activin-Actrii Antagonists and Uses for Treating Anemia In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | |
| US 10,501,547 | ALK7 Binding Proteins and Uses Thereof In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | |
| US 10,695,405 | Compositions and Methods for Treating Pulmonary Hypertension In force · Medium confidence | Acceleron Pharma Inc. | In force | Medium confidence | |
| US 10,722,558 | Compositions and Methods for Treating Pulmonary Hypertension In force · Medium confidence | Acceleron Pharma Inc. | In force | Medium confidence | |
| 12 more term ends in 2037 · Pro | |||||
10 of 22 patents shown. Soonest term end first, then patent number.
Pro members see all 22.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.